GeneOne Life Science, Inc. Logo

GeneOne Life Science, Inc.

Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.

011000 | KO

Overview

Corporate Details

ISIN(s):
KR7011000007
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 20층(여의도동, 파크원NH금융타워(타워2)), 서울특별시

Description

GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-31 00:00
주요사항보고서(자기전환사채매도결정)
Korean HTML 13.5 KB
2025-12-23 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean HTML 71.6 KB
2025-12-23 00:00
[기재정정]유상증자신주발행가액(안내공시)
Korean HTML 10.8 KB
2025-12-23 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean HTML 56.1 KB
2025-09-09 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 13.6 KB
2025-09-08 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 15.9 KB
2025-09-04 00:00
소액공모실적보고서
Korean HTML 25.7 KB
2025-09-04 00:00
유상증자또는주식관련사채등의발행결과(자율공시)
Korean HTML 7.5 KB
2025-09-03 00:00
유상증자또는주식관련사채등의청약결과(자율공시)
Korean HTML 7.1 KB
2025-08-29 00:00
소액공모공시서류(지분증권)
Korean HTML 1.9 MB
2025-08-29 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean HTML 49.7 KB
2025-08-29 00:00
유상증자신주발행가액(안내공시)
Korean HTML 4.2 KB
2025-08-22 00:00
주요사항보고서(유상증자결정)
Korean HTML 36.6 KB
2025-08-20 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.1 KB
2025-08-20 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 102.7 KB

Automate Your Workflow. Get a real-time feed of all GeneOne Life Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GeneOne Life Science, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GeneOne Life Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Circio Holding ASA Logo
Clinical-stage company developing circular RNA medicines and immunotherapies.
Norway
CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
A cancer diagnostics developer creating a blood test for early lung cancer detection.
United Kingdom
CIZ
CJ Bioscience Logo
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
South Korea
311690
Climb Bio, Inc. Logo
Clinical-stage biotech developing therapies for immune-mediated diseases.
United States of America
CLYM
CODEXIS, INC. Logo
A protein engineering company developing enzymes for therapeutics and life sciences.
United States of America
CDXS
COGNITION THERAPEUTICS INC Logo
Clinical-stage company developing oral therapeutics for neurodegenerative disorders.
United States of America
CGTX
Combigene AB Logo
A gene therapy company focused on neurological disorders and chronic pain.
Sweden
COMBI
Compugen Ltd. Logo
A clinical-stage company developing cancer immunotherapies using an AI platform.
Israel
CGEN
COMPUGEN LTD Logo
A clinical-stage company using AI to discover cancer immunotherapy drug targets.
United States of America
CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies and provides non-clinical CRO preclinical services.
South Korea
166480

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.